GlassScriptPhysician profile
Sarah Knoth
NPI 1083245088
$2,658.32
in general payments reported to CMS, 2019-2025
13 companies · $1,174 in 2025
The $1,174 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $261 · 2022: $306 · 2023: $214 · 2024: $703 · 2025: $1,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,111 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.08 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $979.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,340.93 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $415.89 | 2021-2025 | Airsupra, Breztri |
| Novo Nordisk INC | $331.85 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Teleflex LLC | $145.20 | 2024 | Urolift |
| Lilly USA, LLC | $127.59 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $105.30 | 2022 | |
| Boston Scientific Corporation | $40.21 | 2024-2025 | Watchman Flx |
| Biohaven Pharmaceuticals, INC. | $38.04 | 2021 | |
| Medtronic, INC. | $34.77 | 2024-2025 | Intellis Adaptivestim, Venaseal |
| Exact Sciences Corporation | $28.61 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $20.46 | 2023 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $17.57 | 2025 | Proquad, Vaxneuvance, Vaxelis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Knoth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.